Cincinnati · Montgomery · Edgewood, KY By appointment · Most insurance accepted
Contact
Request a Consultation

RegenLife Centers · Physician-led care

Ozone Therapy

What It Is and How It Supports Healing

Published on November 10th, 2026

Caitlyn Benton
Written by
Caitlyn Benton
Dr. Zeeshan Tayeb
Reviewed and Approved by
Dr. Zeeshan Tayeb

The 48-year-old who arrives at an integrative medicine clinic with a diagnosis list that spans three specialties, fibromyalgia confirmed by rheumatology, a herniated disc at L4-L5 managed with epidural steroids that each bought six weeks of partial relief before the axial pain returned, and a fatigue so entrenched that three months of iron supplementation and a thyroid panel reading "within normal limits" failed to explain it, who has taken NSAIDs until her gastroenterologist recommended she stop, who has completed two rounds of physical therapy whose gains eroded within months of discharge, who wonders at each appointment why no clinician has attempted to address the underlying biological environment her symptoms keep pointing toward: this patient has almost certainly not been offered the treatment that addresses the cellular dysfunction common to all three of her presentations simultaneously. The patient handed another corticosteroid injection for a joint that has been inflamed, treated, reflamed, and retreated for four years, never having been offered a regenerative, biologically active alternative that works with the tissue's repair capacity rather than suppressing it, is being managed by the structural minimum of a condition that modern oxidative and regenerative medicine is increasingly equipped to address at the level it actually operates.

Ozone therapy at RegenLife Centers for Integrative Pain & Weight Management begins from a clinically substantiated premise that the standard pharmacological and interventional management pathway rarely reflects: that medical ozone, a precisely concentrated, calibrated form of O3 produced from pharmaceutical-grade oxygen, is an active biological agent with well-documented mechanisms at the cellular, immune, and vascular level, and that the conditions for which it demonstrates the most compelling clinical evidence, chronic musculoskeletal pain, degenerative joint disease, lumbar disc herniation, refractory wounds, fibromyalgia, and systemic immune dysregulation, are precisely the conditions that cyclic steroid injection, long-term NSAID use, and pharmacological suppression have failed to biologically resolve for millions of patients who deserved more than symptom management.

Close-up of sterile syringes aligned on a light blue surface, highlighting medical equipment.Close-up of sterile syringes aligned on a light blue surface, highlighting medical equipment.

Key Takeaways

  • Medical ozone therapy is practiced in over 50 countries and by more than 30,000 ozone therapists worldwide: including as a mainstream medical procedure in Germany, Italy, Russia, Spain, and Cuba, and works by triggering a dose-controlled oxidative eustress response that activates the body's endogenous antioxidant and repair systems without causing cellular damage
  • An aggregated dataset of 6,665 patients receiving intradiscal ozone for lumbar disc herniation reported complete pain elimination in 80% and meaningful improvement in an additional 12%, at 5 and 10-year follow-up: outcomes that surgical management does not consistently replicate at equivalent durability
  • Prolozone therapy: the combination of medical ozone, procaine, and targeted nutritional cofactors injected directly into joints and soft tissues, addresses the biological repair environment of degenerating articular cartilage, ligaments, and spinal discs at the cellular level, triggering growth factor activation and oxygen delivery to tissue chronically operating below regenerative capacity
  • G6PD deficiency screening is required before treatment, as it is the only absolute contraindication that applies universally; properly administered ozone therapy: never inhaled, always dose-controlled, carries a well-established safety record documented across more than 150 years of clinical use

Understanding What Medical Ozone Therapy Actually Is

O3 Versus Environmental Ozone: A Critical Distinction

The premise that ozone therapy involves breathing a pollutant, the confusion between atmospheric ozone and medical ozone that accounts for much of the skepticism the treatment encounters in standard medical settings, is the first clinical misunderstanding to address. Medical ozone is a three-atom oxygen molecule (O3) produced under controlled conditions by passing pharmaceutical-grade oxygen through a calibrated medical ozone generator, yielding a precise gas mixture at concentrations between 10 and 80 micrograms per milliliter. This is fundamentally different from atmospheric ozone, the environmental pollutant formed by photochemical reactions between vehicle exhaust and sunlight, which is inhaled uncontrolled, at variable concentrations, and is appropriately considered harmful to respiratory tissue.

In medical ozone therapy, inhalation is never a delivery route. Every clinical administration method, injection into blood, joints, or soft tissue; rectal insufflation; topical application to skin, deliberately avoids lung contact. The therapeutic rationale is not about inhaling ozone; it is about using controlled, low-dose oxidative signaling to activate biological pathways that inflammation, tissue degeneration, and chronic disease suppress.

A 150-Year Clinical History

Ozone's first medical applications date to the 1860s, when it was used for wound antisepsis and surgical sterilization; its antimicrobial properties, bactericidal, virucidal, and fungicidal through phospholipid oxidation of cell envelopes, were recognized before the mechanisms underlying them were fully characterized. Today, ozone therapy is a mainstream medical procedure in Germany, where 11,000 physicians practice it, alongside 5,000 in China, 3,500 in Russia, and large practitioner communities across Italy, Spain, Cuba, and more than 50 countries in which it is recognized and legally practiced. Its clinical evidence base spans musculoskeletal medicine, wound care, infectious disease, immune modulation, and regenerative applications, and it is the mechanistic coherence of that evidence base, not simply the geographic distribution of its practitioners, that drives its integration into comprehensive regenerative medicine programs.


How Ozone Works Biologically: The Mechanisms Behind the Effect

Oxidative Eustress and the Nrf2 Pathway

The therapeutic mechanism of medical ozone is grounded in hormesis, the biological principle by which a low-dose stressor activates endogenous defense and repair systems without causing the cellular damage that a higher dose would produce. When ozone contacts blood or tissue fluids, it reacts with polyunsaturated fatty acids and water to produce hydrogen peroxide (H2O2) and lipid ozonization products (LOPs), transient reactive species that function as biological signal transducers rather than purely damaging agents. These molecules activate the Nrf2/Keap1/ARE signaling cascade, the master regulator of cellular antioxidant defense, inducing upregulation of superoxide dismutase, catalase, and glutathione peroxidase: the endogenous enzymes responsible for neutralizing the oxidative load that chronic disease, inflammation, and tissue degeneration produce. Clinical evidence confirms this mechanism operates in human patients: medical ozone promotes Nrf2 phosphorylation and reduces pro-inflammatory cytokines in multiple sclerosis patients at therapeutic doses.

This is the biological logic that distinguishes ozone therapy from pharmacological anti-inflammation: rather than suppressing the inflammatory pathway from outside, ozone activates the cell's own regulatory systems, the same systems that exercise-induced reactive oxygen species and intermittent fasting activate through analogous hormetic mechanisms.

Improved Oxygen Delivery and Microcirculation

Ozone stimulates red blood cell glycolysis, increasing intracellular 2,3-diphosphoglycerate (2,3-DPG) concentrations, shifting the oxyhemoglobin dissociation curve rightward through the Bohr effect and allowing hemoglobin to release oxygen more readily to hypoxic tissues. This mechanism is clinically significant for conditions where chronic tissue hypoxia drives degeneration: the intervertebral disc, which has no direct blood supply and is entirely dependent on diffusion for oxygen delivery; the osteoarthritic joint, where synovial and subchondral tissue oxygen tension is measurably reduced; and the chronic wound bed, where hypoxia impairs the fibroblast activity and collagen synthesis that healing requires. Ozone additionally improves erythrocyte deformability, the ability of red blood cells to navigate the microvasculature, enhancing perfusion of the capillary beds where tissue repair occurs.

Immune Modulation and Antimicrobial Activity

Controlled ozone exposure modulates immune function through a range of mechanisms: increasing regulatory T-cell (Treg) activity, enhancing natural killer cell responses, improving lymphocyte profiles, boosting macrophage phagocytic function, and reducing the pro-inflammatory cytokine concentrations, TNF-α, IL-1β, IL-6, that drive the chronic inflammatory environment underlying autoimmune conditions, fibromyalgia, and systemic inflammatory pain. The immune-modulating and antimicrobial dimensions of ozone therapy are supported by experimental data showing ozone achieves 99.9% reduction in viral infectivity at optimal conditions, mechanisms underlying its application in chronic infections, post-viral syndromes, and conditions where pathological immune dysregulation is the primary driver of symptoms.


Ozone Therapy Delivery Methods: Routes, Doses, and Applications

Close-up of an intravenous catheter inserted in a patient's arm for IV-based medical treatmentClose-up of an intravenous catheter inserted in a patient's arm for IV-based medical treatment

Major Autohemotherapy (MAH) and EBOO

Major autohemotherapy (MAH) is the most widely used systemic ozone delivery method: approximately 250 mL of the patient's blood is drawn, mixed with a calibrated oxygen-ozone mixture, and reinfused intravenously over 30–45 minutes. The ozonated blood delivers its oxidative signaling payload systemically, activating the Nrf2 antioxidant cascade, modulating immune parameters, improving red blood cell oxygen delivery, and reducing systemic inflammatory cytokine concentrations. MAH is applied in chronic fatigue, fibromyalgia, autoimmune conditions, chronic infections, and as a systemic complement to localized ozone injections for musculoskeletal presentations where the systemic inflammatory environment is a significant contributor to local tissue degeneration.

EBOO (Extracorporeal Blood Oxygenation and Ozonation) represents a higher-intensity systemic variant in which blood is filtered extracorporeally through a dialysis-like membrane, treated with high-dose ozone, and returned to the patient, applied in more severe presentations including peripheral artery disease and dyslipidemia where conventional MAH's dose range is insufficient.

Rectal Insufflation

Rectal insufflation, administration of approximately 200 cc of ozone gas through a small catheter into the rectum, is the most accessible systemic delivery method after MAH, delivering ozone directly into the portal venous system, where it exerts liver-level metabolic effects and systemic immune modulation without venous access. It is widely used in integrative medicine programs as a primary systemic route, as a home-care complement to clinic-based treatments, and for patients whose venous access or clinical presentation makes blood-based methods less suitable. For systemic conditions including Lyme disease, chronic fatigue syndrome, and fibromyalgia, rectal insufflation is a practical and evidence-supported option for maintaining systemic ozone exposure between MAH sessions.

Prolozone Injections, Topical Ozone, and Dental Applications

Prolozone therapy, combining medical ozone with procaine, B vitamins, vitamin C, magnesium, and proliferant agents injected directly into joints, tendons, and spinal structures, is the application most relevant to the musculoskeletal presentations that constitute the majority of patients seeking regenerative pain management. It is addressed in full detail in the dedicated section below. Topical ozone, applied to enclosed limbs (bagging), ozonated oils, or ozonated water, is the primary delivery route for wound healing applications, delivering direct antimicrobial activity to infected or necrotic wound beds while simultaneously stimulating neovascularization and the oxygen delivery that the healing margin requires. Dental ozone, applied as gas, ozonated water rinse, or ozonated oil, treats caries, periodontal disease, and peri-implant pathology, with a growing systematic review evidence base supporting its clinical effectiveness.


Ozone Therapy for Pain and Musculoskeletal Conditions

Lumbar Disc Herniation and Spinal Pain

The clinical evidence base for ozone therapy in lumbar disc herniation is among the strongest in the ozone literature. An aggregated dataset of 6,665 patients who received intradiscal ozone injections, combining intradiscal and paraspinal oxygen-ozone injection, reported complete pain elimination in 80%, meaningful improvement in an additional 12%, and no improvement in only 7%, at 5 and 10-year follow-up. These outcomes represent durable results in a patient population, symptomatic disc herniation that has failed conservative management, where surgical intervention carries non-trivial complication rates and where the standard conservative pathway of epidural steroids typically produces benefit measured in weeks rather than years.

A meta-analysis of 8 randomized controlled trials involving 1,744 patients confirmed statistically significant improvements in VAS pain scores and Oswestry Disability Index at 1, 6, and 12 months, with decreased analgesic use, supporting intradiscal and periradicular ozone as an evidence-based option before surgical consideration. Related spinal applications are addressed in our posts on degenerative disc disease non-surgical treatment options and spinal stenosis treatment in Cincinnati, OH.

Knee Osteoarthritis

Intra-articular ozone injection for knee osteoarthritis has been the subject of an umbrella review of systematic reviews, the highest tier of evidence synthesis, confirming its efficacy and safety, with research publications on the topic growing from first appearance in 2012 to a peak of 16 peer-reviewed articles in 2021 and 14 in 2023. Short-term outcomes show ozone superior to placebo and corticosteroid injection, with comparable efficacy to hyaluronic acid and dextrose prolotherapy at three months; a 2025 randomized controlled trial combining ozone with hyaluronic acid demonstrated superior pain quality, sleep quality, and quality of life improvements at six-month follow-up compared to hyaluronic acid alone.

The mechanism explains the clinical outcomes: ozone delivered intra-articularly reduces TNF-α and IL-1β concentrations in the joint environment, improves synovial fluid viscosity by stimulating hyaluronan production, and activates the chondrocyte TGF-β pathway that cartilage matrix synthesis requires. Patients whose corticosteroid injection response has diminished over successive treatments, the well-documented phenomenon of steroid tachyphylaxis, are biologically appropriate candidates for ozone therapy, which operates through an entirely different mechanism and does not produce the cartilage-degrading effect that repeated corticosteroid injection does. Our post on knee osteoarthritis: stem cell vs. PRP addresses the comparative context for regenerative joint interventions.


Ozone Therapy for Systemic and Chronic Conditions

Medical professional carefully treating a patient's wound in a clinical setting, supporting tissue healing and recoveryMedical professional carefully treating a patient's wound in a clinical setting, supporting tissue healing and recovery

Wound Healing and Diabetic Foot Ulcers

Topical ozone therapy for chronic, refractory wounds has a systematic review evidence base confirming its clinical effectiveness, with mechanisms operating across the full wound-healing cascade: direct bactericidal activity against the polymicrobial biofilms that prevent healing, stimulation of neovascularization through VEGF upregulation, improved erythrocyte oxygen delivery to the hypoxic wound margin, and activation of the fibroblast proliferation and collagen synthesis that wound closure requires. A prospective comparative study showed topical ozone gas significantly superior to conventional wound management alone for diabetic foot ulcers; recent outcomes data documents 73% reduction in pain scores at 4 weeks and 92% of septic wounds achieving negative bacterial cultures following ozone treatment. The optimal topical dose for diabetic foot ulcers, 40 µg/mL, has been characterized in clinical data, allowing precise, reproducible application. For patients with diabetes, peripheral artery disease, or venous insufficiency who present with wounds that have failed to progress through standard care, ozone's combination of antimicrobial, pro-vascular, and tissue-stimulating mechanisms addresses multiple components of the impaired healing biology simultaneously.

Fibromyalgia and Chronic Fatigue

Ozone therapy has been evaluated in fibromyalgia in a randomized, double-blind, placebo-controlled trial confirming its efficacy as an add-on treatment, the methodological standard against which integrative interventions are most rigorously tested. A 2025 retrospective study of 25 fibromyalgia patients receiving major autohemotherapy showed significant improvements in disease parameters, and a 2023 study of 72 patients receiving 10 MAH sessions over five weeks reported clinically meaningful improvements in pain scores, functional status, and sleep quality, all domains in which fibromyalgia produces its most disabling effects and in which pharmacological management most consistently falls short.

The mechanism is coherent with fibromyalgia's biology: the condition is characterized by central sensitization, elevated systemic inflammatory cytokines, mitochondrial dysfunction, and the impaired cellular energy metabolism that explains its characteristic fatigue. Ozone's activation of the Nrf2 antioxidant system, reduction of TNF-α and IL-1β, improvement of erythrocyte oxygen delivery, and stimulation of mitochondrial function through the HIF-1α pathway addresses multiple components of that biological substrate. Our post on the fibromyalgia diet and inflammation addresses the nutritional context in which ozone therapy's systemic effects are optimized.

Chronic Infections, Multiple Sclerosis, and Immune Dysregulation

Ozone autohemotherapy is applied in chronic viral infections, hepatitis B and C, herpes zoster, recurrent HPV, Lyme disease, and conditions of systemic immune dysregulation, through mechanisms combining direct pathogen reduction and immune system upregulation. For Lyme disease specifically, the evidence base consists primarily of practitioner-led protocols and small studies rather than large randomized controlled trials; the mechanistic rationale, direct antimicrobial action on Borrelia spirochetes, immune activation, and reduction of systemic inflammation, is compelling, and MAH and rectal insufflation are used as adjuncts in comprehensive Lyme protocols by integrative practitioners with extensive clinical experience in this presentation, rather than as standalone treatments whose efficacy has been confirmed in rigorous controlled trials. For multiple sclerosis, ozone autohemotherapy induces measurable cerebral metabolic changes and reduces pro-inflammatory cytokines in human clinical trials, with the Nrf2 activation mechanism providing a biologically coherent rationale for its role in reducing the oxidative stress burden that drives neuroinflammatory disease progression.


Prolozone Therapy: Targeted Joint and Soft Tissue Regeneration

What Prolozone Is and How It Differs from Ozone Injection Alone

Prolozone therapy, developed and systematically documented by Dr. Frank Shallenberger, MD, combines medical ozone with procaine, B vitamins, vitamin C, magnesium, and proliferant agents in a single injection formulated for joints, ligaments, tendons, and spinal structures. Procaine restores cellular membrane potential and addresses neural interference fields that perpetuate the pain cycle at degenerated joints; B vitamins and vitamin C provide the cofactors that cellular energy metabolism and collagen synthesis require; magnesium supports the enzyme activity underlying the repair cascade; and the ozone component delivers its oxidative eustress signal directly to the tissue where the biological repair deficit is most pronounced.

The combined biological effect is greater than ozone injection alone: procaine's membrane restoration allows cells in the degenerated tissue to receive and respond to the growth factor signals that ozone triggers; the nutritional cofactors ensure the repair machinery has the raw material to execute the synthesis those signals call for. For joints whose degeneration has produced a chronic biological depletion, inadequate oxygen, inadequate ATP production, inadequate growth factor responsiveness, prolozone reconstitutes the conditions under which repair becomes possible rather than simply delivering a stimulus into an environment too depleted to respond.

The Evidence Base and Clinical Applications

A randomized controlled trial comparing intra-articular ozone prolotherapy to hypertonic saline for knee osteoarthritis found significant improvements in pain and function in both groups, with no statistically significant difference between groups, confirming ozone prolotherapy as equally effective as hypertonic dextrose prolotherapy, the established comparator, and positioning it within the range of evidence-supported regenerative joint interventions. The ozone component activates TGF-β and fibroblast growth factors that drive cartilage matrix synthesis and connective tissue repair. Clinical series examining prolozone for hip and knee osteoarthritis document significant pain reduction and improved mobility following weekly injection courses. The combination's evidence base differs in architecture from that of individually studied components: while procaine, B vitamins, vitamin C, magnesium, and ozone each have independent evidence bases, the composite prolozone protocol as developed by Shallenberger is primarily supported by practitioner-led clinical data rather than large independent multicenter RCTs, a distinction patients deserve to understand when selecting treatment.

Prolozone's application range mirrors the full scope of regenerative injection medicine: knee, hip, and shoulder osteoarthritis; spinal facet joint arthropathy; ligamentous laxity and chronic joint instability; tendinopathy; sacroiliac joint dysfunction; and lumbar disc herniation presentations where intradiscal delivery is clinically appropriate. Related applications are addressed in our posts on sacroiliac joint pain: PRP and prolotherapy for SI joint dysfunction, facet joint syndrome diagnosis and regenerative treatment, and prolotherapy: how targeted injections rebuild damaged connective tissue.


Safety, Contraindications, and What to Expect

A healthcare professional preparing a targeted injection in a clean clinical environmentA healthcare professional preparing a targeted injection in a clean clinical environment

Why Properly Administered Ozone Therapy Is Safe

More than 150 years of clinical application, a practitioner community exceeding 30,000 worldwide, mainstream medical status in multiple countries, and a comprehensive toxicity review in the peer-reviewed literature confirm that properly administered medical ozone therapy carries a well-established safety profile when performed by trained practitioners using calibrated equipment. The critical safety principles are: never inhaling ozone gas, maintaining therapeutic concentration ranges (10–80 µg/mL depending on application), and screening for the absolute contraindications that apply to specific patient populations. Serious adverse events in the historical literature were largely attributable to improper technique, particularly direct intravenous injection of pure ozone gas rather than ozonated blood, rather than to ozone's biological effects at therapeutic doses administered correctly. Minor adverse effects following MAH, transient nausea, mild fatigue, headache, or rhinitis, are self-limiting and typically resolve within hours.

Absolute Contraindications

G6PD deficiency (Favism) is the universal absolute contraindication to ozone therapy: the ozone-induced reactive oxygen species cascade causes rapid, potentially life-threatening hemolytic anemia in G6PD-deficient individuals, and G6PD screening is a non-negotiable component of the intake evaluation before any systemic ozone treatment begins. Additional absolute contraindications include uncontrolled hyperthyroidism, ozone's metabolic stimulation carries risk of thyrotoxic crisis, active hemorrhage or severe bleeding disorders, thrombocytopenia, and pregnancy. Patients with recent myocardial infarction, severe anemia, or seizure disorders require individualized assessment and are typically treated with modified protocols or alternative modalities.

FDA Status and Clinical Context

The FDA has not approved ozone therapy for any medical condition in the United States, and it is practiced by licensed physicians and naturopathic doctors as an integrative and off-label medical intervention. This regulatory status reflects the FDA approval pathway's requirements, large multicenter randomized trials funded at the scale that pharmaceutical drugs attract, rather than the absence of clinical evidence, which is extensive for key applications including disc herniation and osteoarthritis. Ozone therapy is a mainstream medical procedure recognized and regulated in Germany, Italy, Russia, Spain, Cuba, and more than 50 countries, and is the subject of peer-reviewed clinical literature published in journals indexed in PubMed and major research databases. Patients should understand both the regulatory status and the evidence context when making treatment decisions.


The Integrated Evaluation at RegenLife: Ozone Therapy Cincinnati OH

Comprehensive ozone therapy treatment begins with an evaluation that characterizes the specific biological drivers making ozone therapy the appropriate intervention, and the systemic factors that determine how completely the patient will respond. The diagnostic services at RegenLife assess hormonal status, inflammatory markers, metabolic health, and nutritional cofactor levels that independently determine regenerative treatment response before any injection or systemic protocol is selected. The patient with uncontrolled insulin resistance whose chronic knee osteoarthritis has been managed with quarterly corticosteroids is not a candidate for any regenerative injection program until the metabolic environment that impairs growth factor receptor signaling has been addressed, not because ozone won't work in that environment, but because the response will be a fraction of what the same patient achieves with optimized metabolic and hormonal status.

The lifestyle medicine and hormone therapy protocols at RegenLife address these systemic determinants of regenerative response as an integrated part of the ozone treatment plan: testosterone deficiency and growth hormone insufficiency each reduce the anabolic signaling capacity that tissue repair requires; elevated systemic inflammation drives the catabolic joint and tissue environment that ozone is working to reverse; insulin resistance impairs the cellular energy metabolism that ozone's mitochondrial activation is designed to restore. The patient whose systemic biology is optimized before and alongside ozone treatment is a fundamentally different biological substrate for repair than one whose metabolic drivers remain unaddressed.

The treatment sequence, systemic ozone autohemotherapy or rectal insufflation for patients with inflammatory, immune, or fatigue-related presentations; prolozone and intra-articular ozone injection for musculoskeletal joint and disc pathology; topical ozone for wound healing applications; and integration with PRP therapy, prolotherapy, and physical therapy for the structural and rehabilitative dimensions of musculoskeletal recovery, is selected based on diagnostic findings and the specific biological environment the evaluation characterizes. The goal is not a temporary reduction in symptoms or a single course of injections: it is a biological restoration of the tissue environment that chronic disease, degeneration, and pharmacological suppression have progressively depleted, on a timeline that comprehensive regenerative management makes achievable.


Contact RegenLife Centers to schedule an evaluation or ask which service fits your needs.


Frequently Asked Questions

Find answers to common questions

Ready to Learn More?

To learn more and to find out if you might be a good candidate at RegenLife, schedule a consultation with our team today.

About the Author

Caitlyn Benton

Caitlyn Benton, Research Manager at RegenLife

As Research Manager, Caitlyn Benton oversees the strategic planning and execution of clinical research projects, ensuring all studies adhere to the highest regulatory and ethical standards. With expertise in protocol development and data monitoring, she coordinates multidisciplinary teams to ensure the integrity of our clinical research programs and the accuracy of the insights shared with our patients.

Reviewed and Approved by

Dr. Zeeshan Tayeb

Dr. Zeeshan Tayeb, Medical Director at RegenLife

Interventional Spine, Pain, and Sports Medicine Dr. Zeeshan Tayeb, MD is board-certified in Pain Medicine and Physical Medicine & Rehabilitation, with specialized fellowship training in interventional spine, pain, and sports medicine. He sees patients at Pain Specialists of Cincinnati/RegenLife in Cincinnati, Ohio. Dr. Tayeb's background in physical medicine and rehabilitation has provided the foundation for his comprehensive approach to treating the whole person. Dr. Tayeb has done extensive training and education in both functional and regenerative medicine and specializes in state-of-the-art treatments, including laser therapies, PRP and stem-cell injections, and nutritional and hormonal optimization.

Disclaimer:

As a service to our readers, RegenLife provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Stay Updated With Our Latest News

Check back regularly for new articles and updates about pain management treatments, practice news, and health tips from our team of specialists.

Get In Touch

Same-week consults. Real follow-through.

Tell us what's going on. A coordinator will follow up during office hours to help book your visit.

Request a consultation

Choose the clinic that works for you.

Most new patients can be seen within the same week.

Cincinnati

3328 Westbourne Dr

Cincinnati, OH 45248

(513) 922-2204

Edgewood

162 Barnwood Dr

Edgewood, KY 41017

(859) 331-4159

Montgomery

9989 Montgomery Rd

Montgomery, OH 45242

(513) 922-2204

We accept most major insurance plans

Request